OPDP: Xarelto ad minimized risks

07/1/2013 | Medical Marketing & Media

An ad for Janssen's Xarelto blood thinner that appeared in WebMD Magazine was designed in such a way that risks were minimized and did not appear to be connected to efficacy claims, the FDA Office of Prescription Drug Promotion said in an untitled letter.

View Full Article in:

Medical Marketing & Media

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health